Last reviewed · How we verify
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
The study is a single-arm phase I trial to evaluate the safety, feasibility, and preliminary efficacy of the addition of pembrolizumab and image-guided resection to surgical therapy and chemotherapy for malignant pleural mesothelioma (MPM).
Details
| Lead sponsor | Abramson Cancer Center at Penn Medicine |
|---|---|
| Phase | PHASE1 |
| Status | RECRUITING |
| Enrolment | 20 |
| Start date | Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Mesotheliomas Pleural
Interventions
- Pembrolizumab
- Indocyanine Green (ICG) Image-Guided Surgery
- Cisplatin
- Pemetrexed
Countries
United States